ARCHIVES

Memorial’s Scher Warns FDA About Flaws In Provenge Data, Urges Not To Approve.

This article is from The Cancer Letter archive.

Vol. 33 No. 14 | April 13, 2007

Download PDF Visit The Full Archive

Related Articles

Smoking, Drinking Factors Affect Adherence to Preventive Regimen

September 30, 2011

ASCO Survey Finds Docs’ Quality Time With Patients Down, Due To Paperwork.

June 22, 2001

How a two-faced media covered cancer: Promoting research—and cigarettes

April 29, 2022

UPCI Clarifies Agreement Between Eli Lilly And PCRN.

July 27, 2001

Bosutinib Vs. Imatinib Study Didn’t Meet Primary Endpoint

December 31, 2010

DCPC Forms Decision Network To oversee Chemoprevention

July 16, 1993